Phase 1 Clinical Trials

More and more clients are adopting our innovative Translational Pharmaceutics approach, in order to accelerate their new drugs through early clinical development…

…..but did you know we are also the leading Phase 1 clinical pharmacology company in the UK?

  • 350 employees and growing
  • 11 full-time physicians with 6 Principal Investigators
  • Medical Director with PI experience of over 200 clinical studies
  • 45 Phase 1 CTA submissions annually (more than any other UK unit)
  • Average CTA approval time of 17 days with 100% success rate
  • 85 bed purpose built clinical unit
  • 7,500 active healthy volunteers on our database, 98% would return to volunteer again
  • 70 CDISC compliant datasets issued in the past 2 years
  • Draft CSRs delivered within 8 weeks of LSLD

All studies are conducted to the highest standards with meticulous attention to detail by our experienced clinical team.

Your Project Manager will guide the study to successful delivery on time and to budget.                            

Find out more about our clinical pharmacology programs and access our fact sheet here.

Get in touch and explore how we can help you design and implement the best clinical pharmacology program for your molecule.